Acquisition announcement

Sanofi-aventis SA, a French-based pharmaceutical company, has announced its agreement to purchase Massachusetts-based biotechnology firm Genzyme.

The purchase price for the acquisition is approximately $20.1 billion, and the Boards of Directors...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch